Literature DB >> 16685650

The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males.

Stephen R F Twigg1, Kazuya Matsumoto, Alexa M J Kidd, Anne Goriely, Indira B Taylor, Richard B Fisher, A Jeannette M Hoogeboom, Irene M J Mathijssen, M Teresa Lourenco, Jenny E V Morton, Elizabeth Sweeney, Louise C Wilson, Han G Brunner, John B Mulliken, Steven A Wall, Andrew O M Wilkie.   

Abstract

Craniofrontonasal syndrome (CFNS) is an X-linked disorder that exhibits a paradoxical sex reversal in phenotypic severity: females characteristically have frontonasal dysplasia, craniosynostosis, and additional minor malformations, but males are usually mildly affected with hypertelorism only. Despite this, males appear underrepresented in CFNS pedigrees, with carrier males encountered infrequently compared with affected females. To investigate these unusual genetic features of CFNS, we exploited the recent discovery of causative mutations in the EFNB1 gene, which encodes ephrin-B1, to survey the molecular alterations in 59 families (39 newly investigated and 20 published elsewhere). We identified the first complete deletions of EFNB1, catalogued 27 novel intragenic mutations, and used Pyrosequencing and analysis of nearby polymorphic alleles to quantify mosaic cases and to determine the parental origin of verified germline mutations. Somatic mosaicism was demonstrated in 6 of 53 informative families, and, of 17 germline mutations in individuals for whom the parental origin of mutation could be demonstrated, 15 arose from the father. We conclude that the major factor accounting for the relative scarcity of carrier males is the bias toward mutations in the paternal germline (which present as affected female offspring) combined with reduced reproductive fitness in affected females. Postzygotic mutations also contribute to the female preponderance, whereas true nonpenetrance in males who are hemizygous for an EFNB1 mutation appears unusual. These results highlight the importance of considering possible origins of mutation in the counseling of families with CFNS and provide a generally applicable approach to the combined analysis of mosaic and germline mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685650      PMCID: PMC1474108          DOI: 10.1086/504440

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.

Authors:  R Trappe; F Laccone; J Cobilanschi; M Meins; P Huppke; F Hanefeld; W Engel
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

2.  Low level mosaicism detectable by DHPLC but not by direct sequencing.

Authors:  A C Jones; J R Sampson; J P Cheadle
Journal:  Hum Mutat       Date:  2001-03       Impact factor: 4.878

3.  Crystal structure of an Eph receptor-ephrin complex.

Authors:  J P Himanen; K R Rajashankar; M Lackmann; C A Cowan; M Henkemeyer; D B Nikolov
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

4.  Expanding the phenotype of craniofrontonasal syndrome: two unrelated boys with EFNB1 mutations and congenital diaphragmatic hernia.

Authors:  Pradeep C Vasudevan; Stephen R F Twigg; John B Mulliken; Jackie A Cook; Oliver W J Quarrell; Andrew O M Wilkie
Journal:  Eur J Hum Genet       Date:  2006-04-26       Impact factor: 4.246

5.  Control of skeletal patterning by ephrinB1-EphB interactions.

Authors:  Amelia Compagni; Malcolm Logan; Rüdiger Klein; Ralf H Adams
Journal:  Dev Cell       Date:  2003-08       Impact factor: 12.270

6.  Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal age.

Authors:  R P Ketterling; E Vielhaber; X Li; J Drost; D J Schaid; C K Kasper; J A Phillips; M A Koerper; H Kim; C Sexauer; R Gruppo; R Ambriz; R Paredes; S S Sommer
Journal:  Hum Genet       Date:  1999-12       Impact factor: 4.132

7.  Somatic mosaicism in hemophilia A: a fairly common event.

Authors:  M Leuer; J Oldenburg; J M Lavergne; M Ludwig; A Fregin; A Eigel; R Ljung; A Goodeve; I Peake; K Olek
Journal:  Am J Hum Genet       Date:  2001-06-14       Impact factor: 11.025

Review 8.  Clinical and genetic aspects of craniofrontonasal syndrome: towards resolving a genetic paradox.

Authors:  Peter Wieacker; Ilse Wieland
Journal:  Mol Genet Metab       Date:  2005 Sep-Oct       Impact factor: 4.797

9.  Somatic and germline mosaic mutations in the doublecortin gene are associated with variable phenotypes.

Authors:  J G Gleeson; S Minnerath; R I Kuzniecky; W B Dobyns; I D Young; M E Ross; C A Walsh
Journal:  Am J Hum Genet       Date:  2000-07-27       Impact factor: 11.025

10.  Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.

Authors:  L Kluwe; V Mautner; B Heinrich; R Dezube; L B Jacoby; R E Friedrich; M MacCollin
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

View more
  28 in total

1.  Craniosynostosis.

Authors:  David Johnson; Andrew O M Wilkie
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 2.  De novo mutations in human genetic disease.

Authors:  Joris A Veltman; Han G Brunner
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

3.  An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

Authors:  Marian Seda; Maartje Geerlings; Peggy Lim; Jeshmi Jeyabalan-Srikaran; Ann-Christin Cichon; Peter J Scambler; Philip L Beales; Victor Hernandez-Hernandez; Andrew W Stoker; Dagan Jenkins
Journal:  Mol Syndromol       Date:  2018-07-21

4.  Four novel mutations in EFNB1 in Indian patients with craniofrontonasal syndrome.

Authors:  Antonia Howaldt; Sheela Nampoothiri; Dhanya Yesodharan; Suhas Udayakumaran; Pramod Subash; Uwe Kornak
Journal:  J Hum Genet       Date:  2019-07-08       Impact factor: 3.172

5.  Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1.

Authors:  Weirong Xing; Jonghyun Kim; Jon Wergedal; Shin-Tai Chen; Subburaman Mohan
Journal:  Mol Cell Biol       Date:  2009-12-07       Impact factor: 4.272

6.  Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1.

Authors:  M E P van den Elzen; S R F Twigg; J A C Goos; A J M Hoogeboom; A M W van den Ouweland; A O M Wilkie; I M J Mathijssen
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

7.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

8.  The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function.

Authors:  Roman Makarov; Bernhard Steiner; Zoran Gucev; Velibor Tasic; Peter Wieacker; Ilse Wieland
Journal:  BMC Med Genet       Date:  2010-06-17       Impact factor: 2.103

9.  Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes.

Authors:  Anne Goriely; Helen Lord; Jasmine Lim; David Johnson; Tracy Lester; Helen V Firth; Andrew O M Wilkie
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

10.  Additional EFNB1 mutations in craniofrontonasal syndrome.

Authors:  Deeann Wallis; Felicitas Lacbawan; Mahim Jain; Vazken M Der Kaloustian; Carlos E Steiner; John B Moeschler; H Wolfgang Losken; Ilkka I Kaitila; Stephen Cantrell; Virginia K Proud; John C Carey; Donald W Day; Dorit Lev; Ahmad S Teebi; Luther K Robinson; H Eugene Hoyme; Nadia Al-Torki; Jacqueline Siegel-Bartelt; John B Mulliken; Nathaniel H Robin; Dolores Saavedra; Elaine H Zackai; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.